Ogenix

Fort Lauderdale, United States Founded: 2003 • Age: 23 yrs
Transdermal oxygen therapy for wound healing is developed and marketed.
Annual revenue - Latest available
Total funding $3.7M 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About Ogenix

Ogenix is a company based in Fort Lauderdale (United States) founded in 2003. Ogenix has raised $3.66 million across 1 funding round. Ogenix offers products and services including EPIFLO and Wound Supplies. Ogenix operates in a competitive market with competitors including Siren, Reapplix, PulseFlow, TexiSense and Fovera Orthodesign, among others.

  • Headquarter Fort Lauderdale, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Ogenix, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $3.66 M (USD)

    in 1 rounds

  • Latest Funding Round
    $3.66 M (USD), Series A

    Jun 01, 2005

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ogenix

Ogenix offers a comprehensive portfolio of products and services, including EPIFLO and Wound Supplies.

Product name locked
Category locked
Primary

Portable device for continuous oxygen delivery to wounds.

Product name locked
Category locked
Locked

Products supporting wound care and healing processes.

Funding Insights of Ogenix

Ogenix has successfully raised a total of $3.66M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.66 million completed in June 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Ogenix

Investments
Premium access

Investment portfolio details for Ogenix

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ogenix

Premium access

Detailed financials for Ogenix

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ogenix Comparisons

Ogenix Primary company
Description
Transdermal oxygen therapy for wound healing is developed an...
Location
Fort Lauderdale, United States
Founded Year
2003
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Ogenix

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ogenix

Ogenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Siren, Reapplix, PulseFlow, TexiSense and Fovera Orthodesign, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Innovative foot care solutions are provided by Siren.
Locked Locked Locked
Developer of patch system for wound healing
Locked Locked Locked
Diabetic foot ulcers are treated with a boot-shaped compression device.
Locked Locked Locked
Smart socks and orthotic supports to prevent pressure ulcers in patients with sensory loss
Locked Locked Locked
Online retailer of ergonomic cushions, pillows, and health support products for daily use.
Premium access

Detailed competitors of Ogenix

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ogenix

Premium access

Complete news archive for Ogenix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ogenix

Ogenix was founded in 2003 and raised its 1st funding round 2 years after it was founded.

Ogenix is headquartered in Fort Lauderdale, United States. It is registered at Fort Lauderdale, Florida, United States.

Ogenix is a funded company, having raised a total of $3.66M across 1 funding round to date.

Ogenix develops and markets the Epiflo which is used for the treatment of wounds which are complications of diabetes, wherein the device provides a flow of continuous pure oxygen directly to the wound bed. The device received FDA 510(k) clearance (K120764), CE Mark, and is also cleared by Health Canada. The device has been used by doctors, hospitals, skilled nursing facilities, and long-term care facilities for treatment of bed sores, diabetic foot ulcers, venous leg ulcers, skin grafts, burns, etc.

Ogenix's top competitors include Siren, Reapplix and PulseFlow.

Ogenix offers EPIFLO and Wound Supplies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available